ANDERA PARTNERS

13D and 13G Filings

Issuer % of Class Filed
Schedule 13G · 3 securities · passive
Inventiva S.A. 13G/A
IVA · 46124U107
6.7% 10/27/2026
Event 9/30/2026
Evommune, Inc. 13G/A
EVMN · 30054Y107
3.9% 8/14/2026
Event 6/30/2026
Mineralys Therapeutics, Inc. 13G/A
MLYS · 603170101
4.2% 8/14/2025
Event 6/30/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.